Browsing by Author "0104047"
Now showing items 1-7 of 7
-
A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent.
Barton, KL; Becher, Oren J; Berlow, N; Chung, A; Cordero, FJ; Crabtree, DM; Halvorson, KG; ... (13 authors) (PLoS One, 2015)Diffuse intrinsic pontine gliomas (DIPGs) represent a particularly lethal type of pediatric brain cancer with no effective therapeutic options. Our laboratory has previously reported the development of genetically engineered ... -
A Testosterone Metabolite 19-Hydroxyandrostenedione Induces Neuroendocrine Trans-Differentiation of Prostate Cancer Cells via an Ectopic Olfactory Receptor.
Abaffy, Tatjana; Bain, James R; Bruguera, Elisa; Kim, So Young; Lodha, Shweta; Matsunami, Hiroaki; Muehlbauer, Michael J; ... (9 authors) (Frontiers in oncology, 2018-01)Olfactory receptor OR51E2, also known as a Prostate Specific G-Protein Receptor, is highly expressed in prostate cancer but its function is not well understood. Through in silico and in vitro analyses, we identified 24 agonists ... -
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.
McLendon, Roger; Yan, Hai; Bigner, Darell; He, Yiping; Spasojevic, Ivan; Rasheed, Ahmed; Lopez, Giselle; ... (12 authors) (Cancer research, 2013-01)Point mutations at Arg132 of the cytoplasmic NADP(+)-dependent isocitrate dehydrogenase 1 (IDH1) occur frequently in gliomas and result in a gain of function to produce the "oncometabolite" D-2-hydroxyglutarate (D-2HG). ... -
Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates.
Bourland, JD; Chao, Nelson J; Chen, BJ; Chute, JP; Cline, JM; Daher, P; Deoliveira, D; ... (16 authors) (PLoS One, 2010-06-16)Medications that can mitigate against radiation injury are limited. In this study, we investigated the ability of recombinant human growth hormone (rhGH) to mitigate against radiation injury in mice and nonhuman primates. ... -
Mutant IDH1 is required for IDH1 mutated tumor cell growth.
Yan, Hai; Bigner, Darell; He, Yiping; Spasojevic, Ivan; Pirozzi, Christopher; Lopez, Giselle; Jin, Genglin; ... (10 authors) (Oncotarget, 2012-08)Frequent somatic hotspot mutations in isocitrate dehydrogenase 1 (IDH1) have been identified in gliomas, acute myeloid leukemias, chondrosarcomas, and other cancers, providing a likely avenue for targeted cancer therapy. ... -
Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain.
Chen, Y; Fan, P; Gooden, DM; Guilak, Farshid; Kanju, Patrick; Lee, SH; Lee, W; ... (15 authors) (Sci Rep, 2016-06-01)TRPV4 ion channels represent osmo-mechano-TRP channels with pleiotropic function and wide-spread expression. One of the critical functions of TRPV4 in this spectrum is its involvement in pain and inflammation. However, few ... -
Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential.
Rebouças, JS; Spasojević, Ivan (Antioxid Redox Signal, 2010-09-15)Oxidative stress has become widely viewed as an underlying condition in a number of diseases, such as ischemia-reperfusion disorders, central nervous system disorders, cardiovascular conditions, cancer, and diabetes. Thus, ...